Definition of Facial Injectors  

Facial injectors are equipment that combines facial fillers to be injected into the skin to make fine lines, scars, and wrinkles less noticeable. They are utilized during facial surgeries that can last up to 1 to 2 hours. Facial injectors are injected under anesthesia and can cause mild discomfort once the procedure is done. The effect of the facial injectors can last for 6 months to 5 years depending on the type.

Global Facial Injectors Market: Key Insights

Global Facial Injectors Market Highlights Over 2023 - 2035

The global facial injectors market is estimated to garner a revenue of ~USD 30 Billion by the end of 2035 by growing at a CAGR of ~15% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 16 Billion in the year 2022. The primary factor driving the growth of the market is expected to be the surge in the geriatric population who have a higher requirement for anti-aging products to reduce wrinkles and scars. Statistics released by the World Bank stated that in 2021 the number of geriatrics across the globe hit 747,238,580 and is further increasing Y-O-Y.

GET A SAMPLE COPY OF THIS REPORT

The global facial injector market trends such as the growing utilization of cosmetics products and surgeries to match beauty standards are projected to influence the growth of the market positively over the forecast period. For instance, the online sales of cosmetics were stated to be around USD 18 billion by cosmetics retailers in 2020. The main motive of facial injectors is to reduce facial irregularities such as fine lines, wrinkles, fat, contour, and others. Additionally, the skyrocketing prevalence of cosmetic surgeries globally is further estimated to drive the growth of the market throughout the forecast period. As of 2020, approximately 1,300,000 cosmetic surgical procedures took place solely in the United States.

Global Facial Injectors Market: Growth Drivers and Challenges

Growth Drivers

• Growth in the Number of Minimally Invasive Surgery

The revenue exhibited by the minimally invasive surgery segment was estimated to be approximately USD 18 billion and was further projected to reach nearly USD 45 billion by the year 2030.

Minimally invasive surgeries have made it convenient for both the surgeon and receiver to be more comfortable with facial surgeries. These surgeries combine deoxycholic acid, neurotoxins, peels, dermal fillers, and others to offer highly effective and long-lasting results to the person receiving them. Hence, medical technological advancement has promoted facial surgeries across the globe which may become a significant factor to expand the market size over the forecast period.

• Increasing Inclination Toward Aesthetic Beauty

As of 2022, it was observed that approximately USD 8 billion was spent by beauty companies to commercialize their products.

• Remarkable Change in the Perception Toward Men’s Beauty

The entire beauty industry was expected to generate total revenue of around USD 95 billion in 2020, despite a dip in the men’s care segment, which may drop to about USD 270 billion by the year 2030.

• Significant Number of People in the Need of Facial Surgeries

For instance, approximately 25% of women spent their money and time on their skincare during the pandemic COVID-19.

• Higher Prevalence of Facelift Surgeries across the Globe

For instance, in 2020, more than 400,000 facelift surgeries were performed worldwide.

Challenges

• Possibility of Side-Effects Associated with the Facial Injectors

Facial injectors might cause severe infection around the incision site that may result in worsen scarring, swelling, mild pain, and others. Additionally, if fluid builds up under the skin owing to the mild bleeding, it might require another surgery. Hence, such factors are estimated to limit the growth of the market over the forecast period.

• Higher Cost of Facial Injection Procedures

• Expensive Maintenance of the Surgical Equipment

The global facial injectors market is segmented and analyzed for demand and supply by fillers type into collagen, dermal, polymer, synthetic, hyaluronic acid, and others, out of which, the hyaluronic acid segment is estimated to hold the largest share of the market during the forecast period. The growth of the segment can be ascribed to the up-surged utilization of hyaluronic acid in various types of facial surgeries such as facelifts, wrinkle reduction, lip enhancement, and others. For instance, more than 1,000,000 eyelid surgeries, around 850,000 rhinoplasties, and approximately 500,000 face fat grafting were performed across the globe in 2020.

Global Facial Injectors Market Regional Synopsis

The North American facial injectors market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The market in the region is expected to grow on the back of increasing inclination toward facial surgeries, especially among the young population since they get highly influenced by the people or commercials they encounter on social media. For instance, it was projected that over 100,000 people aged between 18 to 75 in the United States receive facelift surgery every year.

Market Segmentation

Our in-depth analysis of the global facial injectors market includes the following segments:

Customize this Report: Request Customization

Key Companies Dominating the Global Facial Injectors Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global facial injectors market that are included in our report are AbbVie Inc., Merck KGaA, Suneva Medical, Ipsen Pharma, Life Sciences, Medytox, SciVision Biotech Inc., Galderma SA, Anika Therapeutics, Inc., Prollenium Medical Technologies, and others.

Global Facial Injectors Market: Latest Developments

• 25 June 2019: AbbVie Inc., announced the complete acquisition of Allergan plc to increase both the companies’ ability to continue to deliver their mission to shareholders and patients.

• 5 April 2022: Merck KGaA, announced the acquisition of the MAST platform from Lonza to advance its bioprocessing capabilities and become a fully integrated ecosystem for advanced process technologies.   

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.